The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

antrum.co.uk

Stage

Growth Equity | Alive

Total Raised

$10K

Last Raised

$10K | 20 yrs ago

About Antrum

Antrum was established in December 2001 as a commercial vehicle to exploit the technical expertise of the Wireless communications laboratory of Loughborough University. Antrum are developing a range of very small footprint antennas that are design to be hidden or blend naturally into their surroundings -- with the increased sensitivity to electromagnetic radiation and its potentially harmful effects, there is a growing need for low visibility antennas for use in sensitive environments.Antrum has been set up to essentially develop a core of mobile communication products and to exploit the resulting IP, via direct sales, licensing and providing services to businesses.The potential market for the technology being developed by Antrum is large and growing, in the UK alone it is expected that at least a million of the antennas that Antrum specialise in will be required even at the simplest phase of application.

Antrum Headquarter Location

Rutland House Loughborough University Campus

Loughborough, LE11 3TU,

United Kingdom

44 778 9933095

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Antrum News

Tuberculosis Biomarkers Market to Eyewitness Massive Growth by key players: Antrum Biotech, QIAGEN, Thermo Fisher Scientific, QuantuMDx

Mar 1, 2022

Search jobs 01-Mar-2022 Tuberculosis Biomarkers Market to Eyewitness Massive Growth by key players: Antrum Biotech, QIAGEN, Thermo Fisher Scientific, QuantuMDx Tuberculosis Biomarkers Market research Report is an inestimable supply of insightful data for business strategists. This Tuberculosis Biomarkers Market study provides extensive data which enlarge the understanding, scope, and application of this report. A specified study of the competitive landscape of the global Tuberculosis Biomarkers Market has allow, providing insights into the corporate profiles, financial position, recent developments, mergers and acquisitions, and therefore the SWOT analysis. This analysis report will provide a patent subject to reader’s concern regarding the overall market situation to further choose on this market project. The report discusses in detail the various important aspects of the Tuberculosis Biomarkers market. The report has an intelligent insight on critical aspects that are essential to good growth in the Tuberculosis Biomarkers market. Some of these features include market size, growth, revenue, sales, demand, risks, threats, opportunities, economic forecast and history, and much more. The report is based on factual data assessed by our research analysts to give our clients a complete overview of the Tuberculosis Biomarkers market landscape and prepare a business canvas accordingly. The Tuberculosis Biomarkers Market report profiles the successive companies, which includes: – Antrum Biotech, QIAGEN, Thermo Fisher Scientific, QuantuMDx, bioMérieux, Abbott, Rapid Biosensor Systems Ltd, GlobalBio Diagnostics Corp., Danaher Corporation, Alere Inc and Cisbio Bioassays. Fact.MR analysts are currently analyzing and coordinating their insights on the effect of COVID-19 across diverse industry verticals. These insights are quite promising for several businesses and ventures to cope up with this unprecedented downturn and take effective strategic decisions to expand and proliferate within a competitive business ecosystem. Enquiry Before Buying: Reasons why you should buy this report: Understand the Current and future of the Tuberculosis Biomarkers Market in both Established and emerging markets. The report assists in relocating the business strategies by accentuate the Tuberculosis Biomarkers business priorities. The report throws light on the segment anticipated to dominate the Tuberculosis Biomarkers industry and market. Forecasts the regions expected to perceive ascension. The newest developments within the Tuberculosis Biomarkers industry and details of the industry leaders alongside their market share and methods. Saves time on the entry-level research as the report contains significant data concentrating growth, size, key players, and segments of the industry. Save time carrying out entry-level research by characterizing the growth, size, major players and segments within the Global Market. Explore Fact.MR’s Trending Report –  https://www.globenewswire.com/en/news-release/2019/03/13/1752555/0/en/Contract-Pharmaceutical-Fermentation-Services-Market-to-Surpass-US-4-Bn-by-2026-as-Adoption-of-Fermentation-Techniques-for-Developing-API-Grows-Fact-MR.html Why choose Fact.MR? Reports published by Fact.MR are a result of the combination of our experts and digital technologies. We thrive to provide innovative business solutions to the clients as well as tailor the reports aligning with the clients’ requisites. Our analysts perform comprehensive research to offer ins and outs of the current market situation. Clients across various time zones tend to utilize our 24/7 service availability. About Fact.MR Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner. Contact:

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.